SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-22-026727
Filing Date
2022-11-10
Accepted
2022-11-10 08:03:37
Documents
87
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q urgn20220930_10q.htm   iXBRL 10-Q 1667573
2 EXHIBIT 10.1 ex_443657.htm EX-10.1 222126
3 EXHIBIT 31.1 ex_418761.htm EX-31.1 17020
4 EXHIBIT 31.2 ex_418762.htm EX-31.2 17005
5 EXHIBIT 32.1 ex_418763.htm EX-32.1 6702
6 EXHIBIT 32.2 ex_418764.htm EX-32.2 6687
  Complete submission text file 0001437749-22-026727.txt   6835129

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA urgn-20220930.xsd EX-101.SCH 69025
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE urgn-20220930_cal.xml EX-101.CAL 51772
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE urgn-20220930_def.xml EX-101.DEF 385698
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE urgn-20220930_lab.xml EX-101.LAB 328534
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE urgn-20220930_pre.xml EX-101.PRE 421449
81 EXTRACTED XBRL INSTANCE DOCUMENT urgn20220930_10q_htm.xml XML 890438
Mailing Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007
Business Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007 972 9 770 7601
UroGen Pharma Ltd. (Filer) CIK: 0001668243 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38079 | Film No.: 221375041
SIC: 2834 Pharmaceutical Preparations